the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Dr Mahathir seeks open proceedings for Batu Puteh RCI, disqualification of panel members

KUALA LUMPUR: Tun Dr Mahathir Mohamad filed an application for judicial review at the High Court here today seeking to have the proceedings of the Royal Commission of Inquiry (RCI) into the handling of issues related to the sovereignty of Batu Puteh, Middle Rocks and South Ledge conducted publicly.

In his supporting affidavit, the former Prime Minister said the RCI’s decision to not hold the proceedings openly to the public was unreasonable.

He filed the application through the legal firm of Law Practice of Rafique, naming RCI chairman Tun Md Raus Sharif and his deputy Tan Sri Zainun Ali as the first and second respondents.

The third to eighth respondents are RCI members Datuk Dr Baljit Singh Sidhu, Datuk Dr Johan Shamsuddin Sabaruddin, Prof Datin Dr Faridah Jalil, Datuk Mohammed Ridha Ham Abd Kadir, Tuan Hai Dickson Dollah and RCI Secretary Zamri Misman.

In the application, Dr Mahathir is seeking a declaration that he is an individual involved in or related to the matter being investigated by the RCI under Section 18 of the Commissions of Inquiry Act 1950 (Act 119).

He is also seeking an order to prohibit Md Raus from acting as the RCI chairman and to prevent Dr Baljit and Mohammed Ridha from being members of the RCI.

Dr Mahathir said Md Raus’s appointment as RCI chairman posed a “real danger of bias” due to existing animosity between Md Raus and himself, which could affect Md Raus’s impartiality in making decisions for the RCI proceedings.

Meanwhile, Dr Mahathir’s lawyer, Muhammad Rafique Rashid Ali, confirmed in a media statement that they had filed the application today.

“An urgent motion has also been filed to expedite a hearing by the Kuala Lumpur High Court (Special Powers Division), considering that June 12 is the date our client has been subpoenaed to attend the RCI proceedings,” the lawyer said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings